Table 1: Comparison between normotensive and hypotensive patients according to demographic characteristics, propofol infusion, diagnosis on admission and past medical history.

Normotensive (n = 47) Hypotensive (n = 53) Unadjusted RR (95% CI) P value
Age (years) 37.3 (14.6) 52.0 (17.1) 1.02[1.01;1.04] < 0.001
Female, n (%) 15 (31.9) 30 (56.6) 1.59[1.09;2.31] 0.035
Weight (kg) 83.6 (11.5) 78.9 (12.4) 0.98[0.96;1.01] 0.049
Indication of Propofol infusion
Sedation on MV 35 (74.4) 37 (69.8) 0.92[0.5;1.70] 0.66
Convulsions 15 (31.9) 13 (24.5)
Rate of propofol infusion (µg/kg/min), median (25th - 75th) 26.0 (5.0) 25.0 (9.0) 0[0;2.e+12] 0.6
Heart rate (beat/min) 90 (13.2) 90 (10) 0.96[0.76;1.2] 0.12Hypoxic index
Hypoxic index 231.27 (77.63) 170.09 (53.02) 0.99[0.99;1] < 0.001
Serum Creatinine (mg/dl) 0.979 (0.235) 2.41 (1.97) 1.19[1.06;1.33] < 0.001
Bicarbonate (mlEq/L) 21.5 (4.7) 17.35 (3.58) 0.9[0.84;0.96] < 0.001
Diagnosis on admission, n (%)
Traumatic brain injury 19 (40.4) 1 (1.8) 0.08[0.01;0.056] < 0.001
Intracranial Hemorrhage 16 (34.0) 11 (20.7) 0.66[0.33;1.32] 0.13
Status epileptics 12 (25.5) 11 (20.7) 0.87[0.44;1.74] 0.55
Heart failure 1 (2.1) 4 (7.5) 1.55[0.56;4.3] 0.35
Respiratory failure 12 (25.5) 21 (39.6) 1.35[0.77;2.35] 0.15
Severe sepsis 0 26 (49.05) 2.68[1.56;4.59] < 0.001
Burn 3 (6.3) 4 (7.5) 1.28[0.46;3.54] 1.00
Snake bite 0 1 (1.8) 1.9[0.26;13.77] 1.00
APACHE II score 7.7 (3.4) 14.7 (5.6) 1.08[1.04;1.13] < 0.001
MAP at initiation of propofol infusion 104 (11) 87 (12) 0.96[0.94;0.98] < 0.001
RRT need n (%) 0 14 (26.4) 2.15[1.13;4.08] 0.002
Past medical history, n (%)
Diabetes 11 (23.4) 26 (49.05) 1.37[0.98 to 1.93] 0.05
Hypertension 12 (25.5) 20 (37.7) 1.29[0.74;2.24] 0.21
Chronic Congestive heart failure 1 (2.1) 5 (9.4) 1.63[0.65;4.10] 0.21
Atrial fibrillation 0 6 (11.3) 2.0[1.63 to 2.44] 0.029
Acute kidney injury 0 23 (43.3) 2.57[1.48;4.45] < 0.001
End stage renal disease 0 7 (13.2) 2.02[1.64 to 2.48] 0.014
Liver cirrhosis 2 (4.2) 9 (16.9) 1.65[1.16 to 2.34] 0.042

MAP: Mean Arterial Pressure; RRT: Renal Replacement Therapy.